Browsing Clinical Studies by author "Hafeez, Shaista"

Now showing items 1-8 of 8

Clinical Outcomes of a Randomized Trial of Adaptive Plan-of-the-Day Treatment in Patients Receiving Ultra-hypofractionated Weekly Radiation Therapy for Bladder Cancer.

Huddart, R; Hafeez, S; Lewis, R; McNair, H; Syndikus, I; Henry, A; Staffurth, J; Dewan, M; Vassallo-Bonner, C; Moinuddin, SA; Birtle, A; Horan, G; Rimmer, Y; Venkitaraman, R; Khoo, V; Mitra, A; Hughes, S; Gibbs, S; Kapur, G; Baker, A; Hansen, VN; Patel, E; Hall, E; HYBRID Investigators (2020-12-11)

Purpose Hypofractionated radiation therapy can be used to treat patients with muscle-invasive bladder cancer unable to have radical therapy. Toxicity is a key concern, but adaptive plan-of the day (POD) image-guided radiation ...
Failing to Close the Gap Between Evidence and Clinical Practice in Radical Bladder Cancer Radiotherapy.

Hafeez, S; Lewis, R; Griffin, C; Hall, E; Huddart, R (2021-01)
Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer.

Hunt, A; Hanson, I; Dunlop, A; Barnes, H; Bower, L; Chick, J; Cruickshank, C; Hall, E; Herbert, T; Lawes, R; McQuaid, D; McNair, H; Mitchell, A; Mohajer, J; Morgan, T; Oelfke, U; Smith, G; Nill, S; Huddart, R; Hafeez, S (2020-11)

Whole bladder magnetic resonance image-guided radiotherapy using the 1.5 Telsa MR-linac is feasible. Full online adaptive planning workflow based on the anatomy seen at each fraction was performed. This was delivered within ...
Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidance.

Hafeez, S; Patel, E; Webster, A; Warren-Oseni, K; Hansen, V; McNair, H; Miles, E; Lewis, R; Hall, E; Huddart, R (2020-05-26)

INTRODUCTION:Patients with muscle invasive bladder cancer (MIBC) who are unfit and unsuitable for standard radical treatment with cystectomy or daily radiotherapy present a large unmet clinical need. Untreated, they suffer ...
Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance.

Hafeez, S; Webster, A; Hansen, VN; McNair, HA; Warren-Oseni, K; Patel, E; Choudhury, A; Creswell, J; Foroudi, F; Henry, A; Kron, T; McLaren, DB; Mitra, AV; Mostafid, H; Saunders, D; Miles, E; Griffin, C; Lewis, R; Hall, E; Huddart, R (2020-12-31)

Introduction Daily radiotherapy delivered with radiosensitisation offers patients with muscle invasive bladder cancer (MIBC) comparable outcomes to cystectomy with functional organ preservation. Most recurrences following ...
Quality assuring "Plan of the day" selection in a multicentre adaptive bladder trial: Implementation of a pre-accrual IGRT guidance and assessment module.

Patel, E; Tsang, Y; Baker, A; Callender, J; Hafeez, S; Hall, E; Hansen, VN; Lewis, R; McNair, H; Miles, E; Huddart, R (2019-11)

Background and purpose Hypofractionated bladder RT with or without image guided adaptive planning (HYBRID) is a multicentre clinical trial investigating "Plan of the Day" (PoD) adaptive radiotherapy for bladder cancer. To ...
The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy.

de Mol van Otterloo, SR; Christodouleas, JP; Blezer, ELA; Akhiat, H; Brown, K; Choudhury, A; Eggert, D; Erickson, BA; Faivre-Finn, C; Fuller, CD; Goldwein, J; Hafeez, S; Hall, E; Harrington, KJ; van der Heide, UA; Huddart, RA; Intven, MPW; Kirby, AM; Lalondrelle, S; McCann, C; Minsky, BD; Mook, S; Nowee, ME; Oelfke, U; Orrling, K; Sahgal, A; Sarmiento, JG; Schultz, CJ; Tersteeg, RJHA; Tijssen, RHN; Tree, AC; van Triest, B; Hall, WA; Verkooijen, HM (2020-01)

<b>Purpose:</b> MR-guided Radiation Therapy (MRgRT) allows for high-precision radiotherapy under real-time MR visualization. This enables margin reduction and subsequent dose escalation which may lead to higher tumor control ...
Toxicity and Survival Outcomes of a Randomized Phase 2 Trial of Hypofractionated Bladder Radiation Therapy in an Elderly Population With or Without Image Guided Adaptive Plan Selection (HYBRID - CRUK/12/055)

Huddart, RA; Henry, A; Khoo, V; Staffurth, J; Syndikus, I; Hansen, V; McNair, H; Hafeez, S; Lewis, R; Parsons, E; Baker, A; Vassallo-Bonner, C; Moinuddin, S; Illambas, J; Birtle, A; Horan, G; Rimmer, Y; Venkitaraman, R; Mitra, A; Hall, E (ELSEVIER SCIENCE INC, 2017-10-01)

Publications Repository

Publications Repository

Browsing Clinical Studies by author "Hafeez, Shaista"

Clinical Outcomes of a Randomized Trial of Adaptive Plan-of-the-Day Treatment in Patients Receiving Ultra-hypofractionated Weekly Radiation Therapy for Bladder Cancer.

Failing to Close the Gap Between Evidence and Clinical Practice in Radical Bladder Cancer Radiotherapy.

Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer.

Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidance.

Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance.

Quality assuring "Plan of the day" selection in a multicentre adaptive bladder trial: Implementation of a pre-accrual IGRT guidance and assessment module.

The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy.

Toxicity and Survival Outcomes of a Randomized Phase 2 Trial of Hypofractionated Bladder Radiation Therapy in an Elderly Population With or Without Image Guided Adaptive Plan Selection (HYBRID - CRUK/12/055)

Browsing Clinical Studies by author "Hafeez, Shaista"

Clinical Outcomes of a Randomized Trial of Adaptive Plan-of-the-Day Treatment in Patients Receiving Ultra-hypofractionated Weekly Radiation Therapy for Bladder Cancer. ﻿

Failing to Close the Gap Between Evidence and Clinical Practice in Radical Bladder Cancer Radiotherapy. ﻿

Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer. ﻿

Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidance. ﻿

Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance. ﻿

Quality assuring "Plan of the day" selection in a multicentre adaptive bladder trial: Implementation of a pre-accrual IGRT guidance and assessment module. ﻿

The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy. ﻿

Toxicity and Survival Outcomes of a Randomized Phase 2 Trial of Hypofractionated Bladder Radiation Therapy in an Elderly Population With or Without Image Guided Adaptive Plan Selection (HYBRID - CRUK/12/055) ﻿

Clinical Outcomes of a Randomized Trial of Adaptive Plan-of-the-Day Treatment in Patients Receiving Ultra-hypofractionated Weekly Radiation Therapy for Bladder Cancer.

Failing to Close the Gap Between Evidence and Clinical Practice in Radical Bladder Cancer Radiotherapy.

Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer.

Protocol for hypofractionated adaptive radiotherapy to the bladder within a multicentre phase II randomised trial: radiotherapy planning and delivery guidance.

Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance.

Quality assuring "Plan of the day" selection in a multicentre adaptive bladder trial: Implementation of a pre-accrual IGRT guidance and assessment module.

The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy.

Toxicity and Survival Outcomes of a Randomized Phase 2 Trial of Hypofractionated Bladder Radiation Therapy in an Elderly Population With or Without Image Guided Adaptive Plan Selection (HYBRID - CRUK/12/055)